Literature DB >> 22921744

Design, synthesis, and biological evaluation of the analogues of glaziovianin A, a potent antitumor isoflavone.

Ichiro Hayakawa1, Akiyuki Ikedo, Takumi Chinen, Takeo Usui, Hideo Kigoshi.   

Abstract

Various analogues of glaziovianin A, an antitumor isoflavone, were synthesized, and their biological activities were evaluated. O(7)-modified glaziovianin A showed strong cytotoxicity against HeLa S(3) cells. Compared to glaziovianin A, the O(7)-benzyl and O(7)-propargyl analogues were more cytotoxic against HeLa S(3) cells and more potent M-phase inhibitors. Furthermore, O(7)-modified molecular probes of glaziovianin A were synthesized for biological studies.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22921744     DOI: 10.1016/j.bmc.2012.08.005

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  3 in total

1.  Structure Optimization of Gatastatin for the Development of γ-Tubulin-Specific Inhibitor.

Authors:  Kana Shintani; Haruna Ebisu; Minagi Mukaiyama; Taisei Hatanaka; Takumi Chinen; Daisuke Takao; Yoko Nagumo; Akira Sakakura; Ichiro Hayakawa; Takeo Usui
Journal:  ACS Med Chem Lett       Date:  2020-03-30       Impact factor: 4.345

2.  Dual Inhibition of γ-Tubulin and Plk1 Induces Mitotic Cell Death.

Authors:  Haruna Ebisu; Kana Shintani; Takumi Chinen; Yoko Nagumo; Shuya Shioda; Taisei Hatanaka; Akira Sakakura; Ichiro Hayakawa; Hideo Kigoshi; Takeo Usui
Journal:  Front Pharmacol       Date:  2021-01-29       Impact factor: 5.810

3.  The γ-tubulin-specific inhibitor gatastatin reveals temporal requirements of microtubule nucleation during the cell cycle.

Authors:  Takumi Chinen; Peng Liu; Shuya Shioda; Judith Pagel; Berati Cerikan; Tien-Chen Lin; Oliver Gruss; Yoshiki Hayashi; Haruka Takeno; Tomohiro Shima; Yasushi Okada; Ichiro Hayakawa; Yoshio Hayashi; Hideo Kigoshi; Takeo Usui; Elmar Schiebel
Journal:  Nat Commun       Date:  2015-10-27       Impact factor: 14.919

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.